• Users Online: 31
  • Print this page
  • Email this page
Year : 2022  |  Volume : 33  |  Issue : 2  |  Page : 63-69

Does the timing of performing robot-assisted radical prostatectomy after prostate biopsy affect the outcome?

1 Division of Urology, Department of Surgery, Kaohsiung Armed Force General Hospital; Department of Urology, E-DA Hospital, Kaohsiung, Taiwan
2 Department of Urology, E-DA Hospital; School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan
3 Department of Urology, E-DA Hospital; Department of Nursing, I-Shou University; Department of Chemical Engineering and Institute of Biotechnology and Chemical Engineering, I-Shou University; School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan
4 Division of Urology, Department of Surgery, Kaohsiung Armed Force General Hospital, Kaohsiung, Taiwan

Correspondence Address:
Victor C Lin
No. 1, Yida Road, Jiaosu Village, Yanchao District, Kaohsiung 82445
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/UROS.UROS_39_21

Rights and Permissions

Purpose: Prostate biopsy induced prostate hemorrhage and periprostate tissue inflammation which raised the concerns of increasing difficulty even in the era of robot-assisted radical prostatectomy (RARP). To evaluate the correlation between postoperative outcomes and the interval after biopsy, we compared surgical outcomes in different time interval (≤4 weeks, 4–8 weeks, and ≥8 weeks). Materials and Methods: We collected patients with localized prostate cancer who underwent RARP by a single experienced surgeon at our institute between April 2016 and February 2019. The complicated statuses such as previously transurethral resection of prostate, grossly nodal positive disease, or locally advanced disease were excluded. A total of 83 patients were enrolled retrospectively according to the regulation of the institutional review board in the institute. The patients were divided into three groups according to the time interval between prostate biopsy and RARP (≤4 weeks, 4-8 weeks and ≥ 8 weeks). The demographic information and perioperative and postoperative outcomes were collected and analyzed. Results: Regarding preoperative characteristics, there were similarities in the three groups. Concerning intraoperative outcomes, statistical difference was observed in mean estimated blood loss (253.1 vs. 158.9 vs. 170.9 ml, P = 0.047). In addition, operative time was similar among three groups (221.9 vs. 248.5 vs. 226.7, P = 0.199). There was no difference in positive surgical margin rate among three groups. The time interval groups did not correlate to prolonged days either urinary catheter indwelling or hospitalization (P > 0.05). There was no difference in decreased erection hardness scores at 12 months between 3 groups (−0.75 vs. −0.77 vs. −0.57, P = 0.556). Conclusion: In our experience, RARP can be effectively and safely performed in different time intervals after prostate biopsy without increasing total operative time or adversely compromising postoperative functionally and oncologic outcomes. However, performing RARP < 4 weeks after prostate biopsy did probably have the risk of increase estimated blood loss.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded222    
    Comments [Add]    

Recommend this journal